Table 1. Demographic data, risk factors and clinical characteristics of HIV-1-infected patients recruited in the study.
| HIV-1 infected population | ||||||
| Male (%) | Female (%) | Total (%) | ||||
| (N = 627) | (N = 40) | (N = 667) | ||||
| Age (yrs) | n = 612 | n = 37 | n = 649 | |||
| 15–29 | 287 | (46.9) | 12 | (32.4) | 299 | (49.2) |
| 30–50 | 283 | (46.2) | 19 | (51.4) | 302 | (42.5) |
| ≥50 | 42 | (6.9) | 6 | (16.2) | 48 | (8.3) |
| Mode of infection | n = 561 | n = 39 | n = 600 | |||
| Homosexual contact | 388 | (69.2) | 0 | (0) | 388 | (64.7) |
| Heterosexual contact | 51 | (9.1) | 20 | (51.3) | 71 | (11.8) |
| Injecting drug use | 116 | (20.7) | 19 | (48.7) | 135 | (22.5) |
| Receipt of blood products | 6 | (1.1) | 0 | (0) | 6 | (1.0) |
| HBV coinfection | n = 280 | n = 21 | n = 301 | |||
| HBsAg, positive | 68 | (24.3) | 3 | (14.3) | 71 | (23.6) |
| HCV coinfection | n = 361 | n = 27 | n = 388 | |||
| HCVAb, positive | 105 | (29.1) | 16 | (59.3) | 121 | (31.2) |
| Antiretroviral treatment | n = 627 | n = 40 | n = 667 | |||
| HAART | 444 | (70.8) | 22 | (55.0) | 466 | (69.9) |
| HIV-1 subtype | n = 262 | n = 10 | n = 272 | |||
| B | 215 | (82.1) | 4 | (40.0) | 219 | (80.5) |
| C | 3 | (1.1) | 0 | (0) | 3 | (1.1) |
| CRF01_AE | 14 | (5.3) | 3 | (30.0) | 17 | (6.3) |
| CRF07_BC | 29 | (11.1) | 3 | (30.0) | 32 | (11.8) |
| CRF08_BC | 1 | (0.4) | 0 | (0) | 1 | (0.4) |